Connect with us

Press Release

ACI quantitative robot-The power of reading the trends

Published

4 years ago

on

In 1962, Everett-Rogers proposed the theory of innovative diffusion, designed to explain how, why, and how quickly new ideas and technologies were spread. The theory explains how a product or technology gains momentum and spreads across a specific population over time. The end result is that people apply a product, technology, or idea. One of the key implications is that the application of a new technology in the population does not occur simultaneously. Instead, certain people and groups are more likely to apply technology at different times, consistent with specific psychological and social characteristics. There are five established applicationcategories for new ideas or products. These categories are defined below.

A The Innovator. “Innovators are adventurous and willing to take the risks. They fundamentally wanted to be the first person to try something new. Their goal is to explore new technologies or innovation and to find opportunities to be drivers of change. 」

B Early App. “Once the benefits of a new innovation start to become obvious, early apps are eager to try. Early apps bought new technology to achieve revolutionary breakthroughs that gave them a huge competitive advantage in their industry. They like to gain more advantages than their peers, and they seem to have the time and money to invest. 」

C Early majority. “The early majority of the mainstream usually focused on innovation in solving specific problems. They look for complete products that are fully tested, adhere to industry standards, and are used by others they know in the industry. They are looking for gradual, proven ways to do what they are already doing. 」

D Later majority. “The late most are risk aversion, applying only new innovations to avoid the embarrassment of being left behind. 」

E The Times. “The outdated people stick to the end. They valued traditional methods of doing things and refused to apply new technologies until they were eliminated by previous systems and forced to do it. 」

Bitcoin has captured the human imagination. Bitcoin’s story is perhaps more tempting than any previous high-tech innovation. It brings the most cutting-edge innovation to one of the foundations of mankind: currency. Given the possibility of revolutionizing such a fundamental concept, Bitcoin underwent several speculative cycles in its brief history. However, it would be a serious mistake to use these cycles as grounds for denying Bitcoin. These cycles are a well-understood psychological phenomenon caused by man’s fascination with new things. Moreover, any excessive emphasis on foam is to see the trees without the forest. Because, in just 12 years, Bitcoin has grown to 135 million users worldwide, with a faster application rate than the Internet, mobile phone, or virtual banking tools, namely PayPal, in the comparable period. At the current application rate, Bitcoin will reach 1 billion users in four years. Bitcoin, like all previous innovative technologies, is following a predictable and transparent application curve, although accelerating.

Such an incremental user base, the dividend period retained to us ordinary people about how long still?

Which track should we choose during the dividend period, and what can we can and do on this track?

These will be left for everyone to sink down to think;

For me personally, why I choose quantitative trading this derivative as a long-term development track, why I choose ACI quantitative robot, below I explain this question from two aspects.

First, the above mentioned Bitcoin development rate and user growth base, then for this market must be more and more user growth base, because this is the market of mankind, is Bitcoin’s original design concept —— decentralization, in the future, more and more people will enter the huge market derived from the digital currency such as bitcoin, Ethereum; the longer time period, one year, two years or five years, this cycle youcan grasp the number of your wealth appreciation (the biggest wealth);

Second, the first thing new users enter the market must face the secondary market, retained in the secondary market will learn currency speculation and trading, so what is the biggest difference between quantitative and labor? To enter the secondary market to do trading, the first is to learn mathematics, physics and chemistry, the second is anti-humanity, to face and accept the market of every market fluctuations, the third is to establish a set of their own trading system and resolutely implement. These three points seem simple, but need the hard conditions: 1, talent; 2, systematic learning and combat; 3,5 or even over 10 years of full-time experience; otherwise why there has been a saying: one profit, two draws, two losses and seven losses. Ask, if every user can make money in the digital money market, where does the money come from? And quantitative trading it is more suitable for ordinary players, it also has a scientific name called algorithm trading, it will replace artificial strategy, with mathematical models and scientific strategy, to achieve a certain conditions, but its profit is a stable long-term absolute value, rather than the short term of wealth; because each of us enter the digital currency secondary market, the original intention is to improve life, achieve wealth growth, increase the happiness index;

Third, why do you choose the ACI quantitative robot as a tool to fry the currency?

1. Select any product to make a comparison, especially the financial industry; here put forward a core: withdrawal rate is linked to risk, and the secondary market price of digital currency fluctuates greatly, a careless will be a large withdrawal, so we choose the product is not its return rate, but two products, product recovery rate is 100%, and 50%, product 20 year rate is 70%, and the withdrawal rate is 10%, the choice is only product 2;

2. Fund utilization rate, not just play finance, as long as you do business you will understand that the nature of business is not related to fund utilization, the greater your capital utilization proves that the more you can do, the more pipeline to profit; (those who play Martin strategy)

3. The concept reflected by the ACI quantitative robot is also consistent with the personal development ideal, It is free and continuously updated and optimized for life, Of course there is no free lunch, After all, everything takes costs, It charges a small transaction fee, To mark 99.99% of the various products on the current market, All exceptions are the lowest 20% profit withdrawals, Take an example here, If 10,000 u profit 1,000 u, Excluding withdrawal servants and exchange fees, Only over 700 u, came up with While the same ACI quantized robot profits 1,000 u, with 10,000 u Remove fees, Final hand 935-940u;

4. API technology interface of trading platform, do quantitative is a core is security and stability, as the three head compliance trading platform —— currency network, I think I don’t need me to introduce, whether from the user base, trading depth or technical security, is the best choice, after all, security and stability is not what we want;

Simply summary, quantification is actually statistics

About Author

Alex Jacob

Alex Jacob is a literature author. He was born in Chicago. Alex passion is writing news articles. He writes number of articles and published it.

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Gastro Center of Maryland Expands Footprint, Bringing Expert Digestive Care to More Communities Across the DMV

Published

7 hours ago

on

December 1, 2025

By

Gastro Center of Maryland (GCM), one of the state’s largest GI practices, announces expansion to serve more patients across the DMV. With locations in Annapolis, Bethesda, Columbia, Gaithersburg, Olney, Riverdale, Silver Spring, Timonium, and White Marsh, GCM offers comprehensive digestive care including colonoscopies, endoscopies, and advanced treatments. State-of-the-art facilities feature onsite pathology and an IBD Infusion Center. Same-week and NextDay appointments available. Now welcoming new patients.

Silver Spring, Maryland, United States, 1st Dec 2025 – Gastro Center of Maryland (GCM), one of the largest and most respected gastroenterology practices in the state, recently announced its continued expansion with the addition of Silver Spring and Bethesda Location. This strategic growth reinforces the organization’s commitment to delivering expert, compassionate digestive care closer to home for patients throughout Maryland and the greater DMV region.

With this expansion, Gastro Center of Maryland now operates 9 locations across the state, including Annapolis, Bethesda, Columbia, Gaithersburg, Olney, Riverdale, Silver Spring, Timonium/Lutherville, and White Marsh. The practice’s growth comes in direct response to increasing demand for specialized gastroenterological services as digestive health conditions continue to rise nationwide.

“Our mission has always been to provide exceptional, patient-centered digestive care to every community we serve,” said Sarah, an employee. “This expansion allows us to bring our expertise, advanced technology, and compassionate approach to even more patients who deserve convenient access to world-class gastroenterology services.”

Gastro Center of Maryland specializes in diagnosing and treating a comprehensive range of digestive and liver conditions, including acid reflux, irritable bowel syndrome (IBS), Crohn’s disease, ulcerative colitis, hepatitis, fatty liver disease, and colon cancer. The practice operates state-of-the-art Ambulatory Surgery Centers equipped with the latest medical technology, offering advanced procedures such as Bravo pH testing, PillCam capsule endoscopy, STRETTA for reflux treatment, and the Orbera gastric balloon system for weight loss.

Patients benefit from GCM’s integrated care model, which includes onsite pathology services and an IBD Infusion Center for faster, more accurate diagnoses and treatments. The practice also offers same-week and NextDay GI appointments, ensuring patients receive timely care when they need it most.

Gastro Center of Maryland accepts most major insurance plans, including private insurance, federally sponsored plans, and covered Maryland plans. New patients are welcome and can schedule appointments by calling (410) 290-6677 or visiting www.gastromaryland.com.

Media Contact

Organization: Gastro Center of Maryland

Contact Person: Daniel Dent

Website: https://www.gastromaryland.com/

Email:
christiang@gastrocenter.com

Contact Number: +14102906677

Address:10301 Georgia Ave #208

City: Silver Spring

State: Maryland

Country:United States

Release id:38186

The post Gastro Center of Maryland Expands Footprint, Bringing Expert Digestive Care to More Communities Across the DMV appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

New Digital Philanthropy Initiative Launched at Asia Philanthropy Forum in Boao

Published

7 hours ago

on

December 1, 2025

By

In a significant move to harness technology for social good, the ECI@Charity Digital Philanthropy Innovation Committee was officially launched today at the Asia Philanthropy Forum in Boao. The establishment of this global platform marks a strategic evolution for ECI, positioning it from an innovation observer to a proactive builder in the philanthropic sector, leveraging the unique opportunities presented by the Hainan Free Trade Port.

Under the theme “Open Collaboration, Innovative Development,” the Forum gathered over 600 delegates from 16 countries and regions, including government officials, heads of international organizations, philanthropists, and leading entrepreneurs. The event was organized by the Hainan Asia Philanthropy Research Institute under the guidance of the China NGO Network for International Exchanges.

A First-of-its-Kind Global Platform

The ECI@Charity Committee stands as the world’s first cross-border platform dedicated to channeling digital innovation toward improving the lives and well-being of persons with disabilities. Its mission is to foster a more inclusive and caring digital society, enabling individuals with disabilities to achieve greater health, happiness, and dignity through technological empowerment.

Dr. Owen Jia, Global Initiator of ECI, addressed the Asian Philanthropy Forum on “ Powering Good with Digital, Reshaping Giving with Innovation “.

“We are bringing technological innovation back to its humanistic roots,” said Dr. Owen Jia, Global Initiator of the ECI Awards. “By focusing on fundamental human needs, we embark on a new journey of ‘Innovation for Good.’ This committee represents a concrete step toward our vision of serving as a ‘Nobel Prize for the innovation field.’”

Dr. Owen Jia (left), Global Initiator of ECI Awards, and Mr. Shouzhen Xu (right), Co-Chairman of Asian Philanthropy Forum and Executive Chairman of ECI@Charity.

To lead this initiative, Dr. Jia has appointed Mr. Xu Shouzhen as the Executive Chairman of ECI@Charity. Mr. Xu, who also serves as Co-Chairman of the Boao Forum for Asian Philanthropy, will spearhead efforts to consolidate top-tier global innovation resources. “Our goal is to build a transformative collaboration platform that delivers practical, tech-driven solutions in areas like digital healthcare and accessible entertainment,” stated Mr. Xu.

Four-Pillar Action Framework

The Committee will drive impact through four core initiatives:

1. Research & Insights: Publishing an annual “White Paper on Digital Life Needs and Technological Innovation for Persons with Disabilities.”

2. Connection & Co-creation: Hosting the “ECI@Charity Tech for Good Innovation Summit” and “Tech for Disability Innovation Marathon.”

3. Catalyzation & Implementation: Establishing an “ECI@Charity Seed Fund” and a curated “Solutions Resource Library.”

4. Recognition & Promotion: Integrating the specialized “ECI@Charity Awards” into the esteemed ECI Awards framework to benchmark excellence.

First Wave of Initiative Projects Launched

Concurrently, the Committee launched three initiative projects: the “Digital Healing” Partnership Program, connecting digital health enterprises with rehabilitation institutions; the “Accessible Gaming” Developers Alliance, formulating and promoting accessible game design standards; and the “Heartvoice Connect” Public Welfare Communication project, utilizing digital technologies to showcase the talents of artists with disabilities.

Launch Projects and Strategic Support

The Committee announced three flagship partnership programs at launch:

· The “Digital Healing” Partnership Program, linking digital health enterprises with rehabilitation institutions.

· The “Accessible Gaming” Developers Alliance, to formulate and promote inclusive game design standards.

· The “Heartvoice Connect” Public Welfare Communication project, using digital tools to amplify the talents of artists with disabilities.

Mr. James George, Deputy Resident Representative of the United Nations Development Programme (UNDP) in China, delivered a speech at the opening ceremony of the Asian Philanthropy Forum.

The initiative received notable support from the international community. Mr. James George, Deputy Resident Representative of the United Nations Development Programme (UNDP) in China, addressed the Forum, underscoring the importance of multi-stakeholder partnerships in achieving sustainable development goals.

2025 Asian Philanthropy Forum

Looking Ahead

Positioned at the new frontier of digital civilization, ECI@Charity will utilize the open policy framework of the Hainan Free Trade Port to aggregate global innovators. It aims to contribute substantively to a more equitable, inclusive, and compassionate digital future, solidifying its transition from an innovation observer to a definitive leader in shaping that future.

About ECI Awards

The ECI Awards (International Awards for Innovation in Business and Marketing), organized by the International Entrepreneurs, Creatives & Innovators Association (IECIA), is a globally recognized accolade celebrating innovation that creates new market value. It honors achievements across business models, products, services, technology, marketing, and social innovation.

Media Contact

Organization: Secretary General of EClAwards Committee

Contact Person: Faye Feng

Website: https://www.eciawards.org.cn

Email: Send Email

City: BOAO

Country:China

Release id:38261

The post New Digital Philanthropy Initiative Launched at Asia Philanthropy Forum in Boao appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation

Published

7 hours ago

on

December 1, 2025

By

Santersus AG Announces Advancement of NucleoCapture into Pivotal Clinical Development strengthened by Strategic Collaboration with Terumo

Zurich, Switzerland, 1st Dec 2025 – Santersus AG today announced the successful completion of its Series A financing, led by Norcliffe, a UK life sciences fund with participation from Terumo Ventures. The financing will support the advancement of Santersus’ NucleoCapture into pivotal clinical development while accelerating progress across Santersus’ broader pipeline.

Santersus has entered a strategic collaboration with Terumo Blood and Cell Technologies to advance NucleoCapture(TM) for the treatment of sepsis, a disease that kills 11M people worldwide each year. The collaboration integrates Santersus’ first-in-class NucleoCapture blood purification device with Terumo BCT’s industry-leading Spectra Optia Apheresis System, creating a novel therapeutic apheresis approach designed to selectively remove neutrophil extracellular traps (NETs)— a major contributor to systemic inflammation and sepsis-related organ dysfunction. NucleoCapture has previously been granted two U.S. FDA Breakthrough Device Designations, including one for the treatment of sepsis.

Under this collaboration, Santersus will lead the pivotal NUC-CAP clinical trial across the United States, United Kingdom, Switzerland and Europe. Terumo BCT will support the clinical development of the program, and Terumo Ventures – the corporate VC arm of Terumo – has invested in Santersus’ Series A financing round to accelerate the development of this technology for a critical unmet need with high mortality.

“Therapeutic apheresis has untapped potential to address serious unmet medical needs,” said Veerle d’Haenens, General Manager of Global Therapy Innovations at Terumo Blood and Cell Technologies. “Our partnership with Santersus reflects our commitment to advancing innovative treatment options for critically ill patients.”

The Series A financing will also support Santersus’ preparation for pivotal clinical trials in systemic lupus erythematosus (SLE), where NucleoCapture has received its second U.S. FDA Breakthrough Device Designation for treatment-refractory disease. The pivotal SLE program addressing an estimated $4bn global treatment market – will expand Santersus’ late-stage clinical portfolio beyond critical care and is expected to begin following the sepsis study launch.

Santersus is also advancing NucleoCapture technology into solid-organ transplantation, including a program designed to perfuse and recondition heavily damaged donor livers prior to transplantation. The global organ transplantation market is projected to reach $61.5bn by 2027. In parallel, Santersus is expanding a NucleoCapture program in lung transplantation focused on the prevention of primary graft dysfunction (PGD). Together, these initiatives support the application of NucleoCapture across solid-organ transplantation.

Santersus is also advancing early-stage development of NucleoCapture for Alzheimer’s disease, with an exploratory clinical study under way to assess its effects on amyloid removal. The global Alzheimer’s therapeutics market is valued at approximately $5bn in 2025 and is projected to double over the next decade.

These integrated programs reflect Santersus’ transition towards a multi-indication, late-stage clinical development company and position Santersus as a leading developer of NETs-targeted therapeutic apheresis technologies across critical care, autoimmunity, solid-organ transplantation, and neurodegeneration.

About Santersus AG

Zurich-based Santersus AG is a biotechnology company developing NucleoCapture, a novel, patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA (cfDNA) and neutrophil extracellular traps (NETs). NucleoCapture has received two U.S. FDA Breakthrough Device Designations: one for the treatment of sepsis and one for systemic lupus erythematosus. Santersus is advancing a diversified clinical pipeline across sepsis, systemic lupus erythematosus, solid-organ transplantation (liver and lung), and Alzheimer’s disease.

For more information, please visit www.santersus.com

Media Contact

Organization: Santersus AG

Contact Person: Aleksander Zaporoztsev

Website: https://www.santersus.com

Email:
info@santersus.com

Country:Switzerland

Release id:38172

The post Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us